Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

CRNXCRNX
15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in CRINETICS PHARMACEUTICALS IN

WELLINGTON MANAGEMENT GROUP LLP holds 7.1M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $266.8M as of 2026-Q2. The position was decreased (-12.6% shares). CRNX represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$266.8M

Current Shares

7.1M

Total Value Change

+$215.5M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7.1M
-12.6%
$266.8M0.0%$37.42
0
2026-Q1
Increased
8.2M
+1.5%
$296.3M0.1%$36.32
31
2025-Q4
Decreased
8M
-4.1%
$374.2M0.1%$46.55
0
2025-Q3
Increased
8.4M
+44.3%
$349.1M0.1%$41.65
42
2025-Q2
Decreased
5.8M
-15.7%
$167M0.0%$28.76
0
2025-Q1
Decreased
6.9M
-0.8%
$231.1M0.0%$33.54
0
2024-Q4
Increased
7M
+55.9%
$355.4M0.1%$51.13
44
2024-Q3
Decreased
4.5M
-3.5%
$227.9M0.0%$51.10
0
2024-Q2
Increased
4.6M
+55.5%
$206.9M0.0%$44.79
43
2024-Q1
Decreased
3M
-8.4%
$139.1M0.0%$46.81
0
2023-Q4
Decreased
3.2M
-10.8%
$115.5M0.0%$35.58
0
2023-Q3
Increased
3.6M
+1.1%
$108.3M0.0%$29.74
30
2023-Q2
Decreased
3.6M
-0.9%
$64.9M0.0%$18.02
0
2023-Q1
Increased
3.6M
+29.6%
$58.4M0.0%$16.06
37
2022-Q4
New
2.8M
-
$51.3M0.0%$18.30
41

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used